Comprehensive Stability Study Protocol for Intrathecal Drugs
This protocol outlines the procedures for conducting stability studies on drugs administered via the intrathecal route, with a focus on sterility, potency, and chemical stability under stringent storage conditions.
| Parameter | Details |
|---|---|
| Product Name | [Intrathecal Drug Name] |
| Batch Number | [Batch Number] |
| Objective | To evaluate the stability of intrathecal drugs under stringent environmental conditions. |
| Test Parameters |
– Sterility – Potency  – Appearance |
| Storage Conditions | [e.g., 2-8°C, 25°C/60% RH] |
| Test Intervals | [Specify intervals: 0, 3, 6, 12 months, etc.] |
| Acceptance Criteria | No significant changes in sterility, potency, or appearance. |
| Regulatory Guidelines | ICH Q1A(R2), FDA, EMA |
| Signatories | QA, QC, Regulatory Affairs |